Randomized Phase 3 Trial of Dose Escalation (80 vs 70 Gy) in High-Risk Prostate Cancers Combined With Long-term Androgen Deprivation: GETUG-AFU 18 Trial, Acute and 1-Year Toxicities

Affiliation auteursAffiliation ok
TitreRandomized Phase 3 Trial of Dose Escalation (80 vs 70 Gy) in High-Risk Prostate Cancers Combined With Long-term Androgen Deprivation: GETUG-AFU 18 Trial, Acute and 1-Year Toxicities
Type de publicationJournal Article
Year of Publication2015
AuteursHennequin C., Richaud P.M, Roca L., Silva M., Latorzeff I., Beckendorff V., Carrie C., Benyoucef A., Hasbini A., Supiot S., Ronchin P., Wachter T., Azria D., Cailleux P.E, Cormier L., Habibian M., Delaroche G.
JournalINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Volume93
PaginationS44-S45
Date PublishedNOV 1
Type of ArticleMeeting Abstract
ISSN0360-3016
DOI10.1016/j.ijrobp.2015.07.107